Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trientine capsule pharmacokinetics crossover study in healthy volunteers
NL-OMON46237Active, not recruiting
- Sponsor
- Univar Solutions
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trientine in Wilson disease (WD) (3 arms), sponsored by Univar Solutions. Primary endpoints: Trientine Cmax, Trientine AUC0-t and 4 more. Started Jul 2018; status: active, not recruiting.
02
Drugs
trientine
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on NL-OMON46237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46237.